He aha ʻo Deucravacitinib: Nā hoʻohana, ka nui o ka lāʻau, nā hopena ʻaoʻao a me nā mea hou aku

He lāʻau lapaʻau waha hou ʻo Deucravacitinib e kōkua ana i ka mālama ʻana i ka psoriasis plaque maʻamau a koʻikoʻi i nā pākeke. No ka papa o nā lāʻau lapaʻau i kapa ʻia ʻo TYK2 inhibitors, e hana ana ma ka pale ʻana i nā protein kikoʻī e hoʻoulu ai i ka mumū i kou ʻili.

Hōʻike kēia lāʻau lapaʻau i kahi ʻanuʻu nui i mua i ka mālama ʻana i ka psoriasis no ka mea e kuhikuhi ana i ke kumu kumu o ka mumū ma mua o ka mālama ʻana i nā hōʻailona. Lawe ʻoe iā ia ma ke ʻano he pila i hoʻokahi manawa i ka lā, e maʻalahi ai ma mua o nā lāʻau lapaʻau psoriasis ʻē aʻe e koi ana i nā injections a i ʻole nā noi pinepine.

No ke aha e hoʻohana ʻia ai ʻo Deucravacitinib?

Hoʻonohonoho mua ʻia ʻo Deucravacitinib no nā pākeke me ka psoriasis plaque maʻamau a koʻikoʻi e kūpono ana no ka therapy systemic a i ʻole phototherapy. Hiki i kāu kauka ke ʻōlelo aku i kēia lāʻau lapaʻau ke hāʻawi ʻole nā lāʻau lapaʻau topical i ka hōʻoluʻolu lawa a i ʻole ke uhi ʻana o kāu psoriasis i kahi ʻāpana nui o kou kino.

Hoʻolālā kūikawā ʻia ka lāʻau lapaʻau no ka psoriasis plaque, ʻo ia ke ʻano maʻamau o kēia maʻi autoimmune. Hoʻokumu ka psoriasis plaque i nā ʻāpana mānoanoa a me ka unahi ma kou ʻili e hiki ke ʻā, ʻeha, a me ka pilikia o ka naʻau.

E noʻonoʻo maʻamau kāu mea mālama ola kino iā deucravacitinib inā loaʻa iā ʻoe ka psoriasis e pili ana i ka ʻoi aku o 10% o kou wahi kino, a i ʻole inā pili nui ke kūlana i kou maikaʻi o ke ola. He mea kōkua nui ia no ka poʻe i pane ʻole i nā lāʻau lapaʻau ʻē aʻe a i ʻole makemake i kahi lāʻau lapaʻau waha ma mua o nā injections.

Pehea e hana ai ʻo Deucravacitinib?

Hana ʻo Deucravacitinib ma ka pale ʻana i kahi protein kikoʻī i kapa ʻia ʻo TYK2 (tyrosine kinase 2) i loko o kāu ʻōnaehana pale. He kuleana nui kēia protein i ka hoʻoulu ʻana i ka pane mumū e hoʻoulu ai i nā hōʻailona psoriasis.

E manaʻo iā TYK2 he ʻelele e haʻi ana i kāu ʻōnaehana pale e hana i ka mumū. Ma ka pale ʻana i kēia ʻelele, kōkua ʻo deucravacitinib i ka hōʻemi ʻana i ka pane pale nui e alakaʻi ana i nā pā mānoanoa a me ka unahi e hōʻike ana i ka psoriasis.

Ua manaʻo ʻia kēia lāʻau lapaʻau he ikaika iki i hoʻohālikelike ʻia me nā lāʻau lapaʻau psoriasis ʻē aʻe. Ua ʻoi aku ka pahuhopu ma mua o nā lāʻau lapaʻau ʻōnaehana kahiko, ʻo ia hoʻi he liʻiliʻi nā hopena ʻaoʻao a hāʻawi nō naʻe i ka hōʻoluʻolu maikaʻi. Hana mālie ka lāʻau lapaʻau, no laila ʻaʻole paha ʻoe e ʻike i nā hopena piha no kekahi mau pule a i ʻole mau mahina.

Pehea e lawe ai au i ka Deucravacitinib?

E lawe i ka deucravacitinib e like me ke kauoha a kāu kauka, maʻamau hoʻokahi manawa i ka lā me ka ʻole o ka meaʻai. Hiki iā ʻoe ke lawe i kēlā me kēia manawa o ka lā, akā e hoʻāʻo e lawe i ka manawa like i kēlā me kēia lā e kōkua iā ʻoe e hoʻomanaʻo.

E ale i ka papa holoʻokoʻa me ke aniani wai. Mai ʻoki, nau, a ʻokiʻoki paha i ka papa, no ka mea, hiki i kēia ke hoʻopilikia i ka hana ʻana o ka lāʻau lapaʻau i loko o kou kino.

ʻAʻole pono ʻoe e lawe i kēia lāʻau lapaʻau me ka waiū a i ʻole e pale i kekahi mau meaʻai, akā ʻo ka mālama ʻana i kahi hana maʻamau e kōkua i ka hōʻoia ʻana i nā hopena maikaʻi loa. Inā pilikia ʻoe i ka ale ʻana i nā pila, e kamaʻilio me kāu kauka e pili ana i nā hoʻolālā e kōkua ai.

He mea nui e hoʻomau i ka lawe ʻana i ka deucravacitinib inā hoʻomaka ʻoe e ʻoi aku ka maikaʻi. He maʻi maʻi ka Psoriasis, a ʻo ka hoʻōki ʻana i ka lāʻau lapaʻau hiki ke hoʻihoʻi i kāu mau hōʻailona.

Pehea ka lōʻihi e lawe ai au i ka Deucravacitinib?

ʻO ka lōʻihi o ka mālama ʻana i ka deucravacitinib e ʻokoʻa mai kēlā me kēia kanaka a pili i ka maikaʻi o kāu pane ʻana i ka lāʻau lapaʻau. Nui ka poʻe me ka psoriasis e pono i ka mālama lōʻihi e mālama i ka ʻili maʻemaʻe.

E loiloi kāu kauka i kāu pane ma hope o 12 a 16 mau pule o ka mālama ʻana. Inā hana maikaʻi ka lāʻau lapaʻau a ʻaʻole ʻoe e ʻike i nā hopena ʻaoʻao nui, hiki iā ʻoe ke hoʻomau i ka lawe ʻana iā ia no ka manawa pau ʻole.

ʻIke kekahi poʻe i ka maikaʻi i loko o nā pule mua, a ʻo nā mea ʻē aʻe paha e pono i 3 mau mahina e ʻike i nā pōmaikaʻi piha. E nānā kāu mea mālama ola i kou holomua ma o nā nānā maʻamau a hiki ke hoʻololi i kāu hoʻolālā lapaʻau e pili ana i kāu pane.

Mai hooki i ka lawe ʻana i ka deucravacitinib me ka ʻole e kūkākūkā me kāu kauka, no ka mea, hiki i kēia ke alakaʻi i ka piʻi ʻana o kāu mau hōʻailona psoriasis.

He aha nā hopena ʻaoʻao o Deucravacitinib?

E like me nā lāʻau lapaʻau a pau, hiki i ka deucravacitinib ke hana i nā hopena ʻaoʻao, ʻoiai ʻaʻole ʻike nā mea a pau iā lākou. ʻO ka hapa nui o nā hopena ʻaoʻao he maʻalahi a i ka waena a pinepine e hoʻomaikaʻi i ka wā e hoʻoponopono ai kou kino i ka lāʻau.

ʻO nā hopena ʻaoʻao maʻamau āu e ʻike ai, ʻo ia nā maʻi hanu luna, nā poʻo, a me ka maʻi maʻi. Hiki ke hana pinepine kēia i nā pule mua o ka lapaʻau a pinepine e hoʻoponopono iā lākou iho.

Eia nā hopena ʻaoʻao maʻamau e pili ana i kekahi poʻe e lawe ana i ka deucravacitinib:

• Nā maʻi hanu luna e like me ke anu a i ʻole nā maʻi sinus
• Nā poʻo e maʻalahi a i ka waena
• Maʻi maʻi a i ʻole nā noho palupalu
• Nausea a i ʻole ka ʻoluʻolu o ka ʻōpū
• Nā ʻōpū waha a i ʻole nā ʻeha canker
• Ka nalowale o ka lauoho, he maʻalahi a hiki ke hoʻohuli
• Folliculitis (ka mumū o nā follicles lauoho)

Hiki ke mālama ʻia ka hapa nui o kēia mau hopena ʻaoʻao a ʻaʻole pono e hooki i ka lāʻau. Hiki i kāu kauka ke kōkua iā ʻoe e ʻimi i nā ala e hōʻemi ai i kekahi ʻoluʻolu āu e ʻike ai.

ʻOiai ʻaʻole maʻamau, hiki i kekahi poʻe ke ʻike i nā hopena ʻaoʻao koʻikoʻi e pono ai ka lāʻau lapaʻau koke. Aia kēia mau mea i nā hōʻailona o nā maʻi koʻikoʻi, ke kahe ʻana o ke koko a i ʻole ka ʻeha ʻana, a i ʻole nā hopena maʻi maʻi koʻikoʻi.

ʻO nā hopena ʻaoʻao laha akā koʻikoʻi āu e hōʻike koke ai i kāu kauka:

• Nā hōʻailona o ka maʻi nui e like me ke kuni, nā anu, a i ʻole ka ʻūlū mau
• Ke kahe koko ʻano ʻē a i ʻole ka ʻeha
• Nā hopena maʻi āpau nui e like me ka ʻōpala, ka pehu, a i ʻole ka pilikia o ka hanu
• Ka maʻi palahē nui a i ʻole ka mau
• Ka luhi ʻano ʻē a i ʻole ka nāwaliwali

ʻAʻole maʻamau kēia mau hopena ʻaoʻao nui, akā he mea nui e ʻike iā lākou a e hoʻokaʻaʻike i kāu mea mālama ola inā loaʻa iā ʻoe kekahi mau hōʻailona e hopohopo nei.

ʻO wai ka mea pono ʻole e lawe iā Deucravacitinib?

ʻAʻole kūpono ʻo Deucravacitinib no nā mea a pau, a e loiloi pono kāu kauka inā kūpono ia nāu. ʻAʻole pono ʻoe e lawe i kēia lāʻau inā he maʻi ʻoe iā deucravacitinib a i ʻole kekahi o kāna mau mea.

Hiki i kekahi mau maʻi olakino ke hana i ka deucravacitinib kūpono ʻole a i ʻole e koi i ka nānā kūikawā. E nānā pono kāu kauka i kāu mōʻaukala olakino ma mua o ke kau ʻana i kēia lāʻau.

Pono ʻoe e haʻi i kāu kauka inā loaʻa iā ʻoe kekahi o kēia mau maʻi ma mua o ka hoʻomaka ʻana iā deucravacitinib:

• Nā maʻi ikaika a i ʻole ka mōʻaukala o nā maʻi e hoʻi pinepine ana
• Maʻi ate a i ʻole nā hoʻokolohua hana ate ʻano ʻē
• Maʻi kīkī a i ʻole ka hana kīkī i hōʻemi ʻia
• Mōʻaukala o nā koko koko a i ʻole nā maʻi koko
• Ka maʻi ʻaʻai a i ʻole ka mōʻaukala o ka maʻi ʻaʻai
• Nā maʻi ʻōnaehana pale
• Nā lāʻau lapaʻau hou a i ʻole nā hoʻolālā e loaʻa ai nā lāʻau lapaʻau

Pono ka hāpai ʻana a me ka hānai ʻana i ka umauma i ka noʻonoʻo kūikawā. ʻAʻole i hoʻokumu piha ʻia ka palekana o deucravacitinib i ka wā hāpai, no laila e kūkākūkā kāu kauka i nā pilikia a me nā pōmaikaʻi inā hāpai ʻoe a i ʻole e hoʻolālā ana e hāpai.

Inā hānai ʻoe i ka umauma, e kōkua kāu kauka iā ʻoe e kaupaona i nā pōmaikaʻi o ka mālama ʻana i nā pilikia e hiki mai ana i kāu pēpē. Hiki i ka lāʻau lapaʻau ke hele i loko o ka waiū umauma, ʻoiai ʻaʻole ʻike piha ʻia ka nui.

Inoa Brand Deucravacitinib

Loaʻa ʻo Deucravacitinib ma lalo o ka inoa inoa ʻo Sotyktu. ʻO kēia wale nō ka inoa inoa i loaʻa i kēia manawa no kēia lāʻau lapaʻau ma ʻAmelika Hui Pū ʻIa.

Hana ʻia ʻo Sotyktu e Bristol Myers Squibb a ua ʻae ʻia e ka FDA i ka makahiki 2022. Ke loaʻa iā ʻoe kāu kauoha, e ʻike ʻoe iā "Sotyktu" ma ka hue lāʻau, me ka inoa generic "deucravacitinib."

I kēia manawa, ʻaʻohe mana generic o deucravacitinib i loaʻa. Inā he pilikia ke kumukūʻai, e kamaʻilio me kāu kauka e pili ana i nā papahana kōkua maʻi a i ʻole nā koho uhi ʻinikua e kōkua ai i ka hana ʻana i ka lāʻau lapaʻau.

Nā Koho ʻē aʻe no Deucravacitinib

Inā ʻaʻole kūpono ʻo deucravacitinib iā ʻoe a i ʻole ʻaʻole hāʻawi i ka hōʻoluʻolu kūpono, aia kekahi mau lāʻau lapaʻau ʻē aʻe no ka psoriasis mai ka maʻi waena a i ka maʻi nui. Hiki i kāu kauka ke kōkua iā ʻoe e ʻimi i kēia mau koho e pili ana i kāu mau pono a me ka mōʻaukala olakino.

ʻO nā lāʻau lapaʻau waha ʻē aʻe no ka psoriasis me ka methotrexate, cyclosporine, a me apremilast (Otezla). Hana ʻokoʻa kēlā me kēia o kēia mau mea a loaʻa iā lākou nā pōmaikaʻi a me nā hopena ʻaoʻao.

Eia kekahi mau koho lapaʻau ʻē aʻe e noʻonoʻo ai kāu kauka:

• Nā pahu biologic e like me adalimumab (Humira), etanercept (Enbrel), a i ʻole ustekinumab (Stelara)
• Nā lāʻau lapaʻau waha ʻē aʻe e like me apremilast (Otezla) a i ʻole methotrexate
• Phototherapy a i ʻole nā lāʻau lapaʻau māmā
• Nā lāʻau lapaʻau topical no nā hihia maʻalahi a i ʻole ma ke ʻano he lāʻau hui pū
• Nā biologics hou e like me guselkumab (Tremfya) a i ʻole risankizumab (Skyrizi)

ʻO ke koho ʻana i ka lāʻau lapaʻau ʻē aʻe e pili ana i nā mea e like me kou olakino holoʻokoʻa, ka mōʻaukala lapaʻau, nā makemake o ke ola, a me ke koʻikoʻi o kāu psoriasis. E hana pū kāu dermatologist me ʻoe e ʻimi i ke koho kūpono loa.

Ua ʻoi aku ka maikaʻi o Deucravacitinib ma mua o Apremilast?

ʻO Deucravacitinib a me apremilast (Otezla) he mau lāʻau lapaʻau waha no ka psoriasis, akā hana lākou ma nā ʻano hana like ʻole a ua hōʻike i nā pae like ʻole o ka pono i nā hoʻokolohua lapaʻau. ʻO ke koho ma waena o lākou e hilinaʻi ana i kou mau kūlana pilikino a me nā pahuhopu lapaʻau.

Hōʻike nā haʻawina lapaʻau e ʻoi aku ka pono o deucravacitinib ma mua o apremilast no ka loaʻa ʻana o ka ʻili maʻemaʻe a kokoke paha. I nā hoʻokolohua poʻo-i-poʻo, ʻoi aku ka nui o nā kānaka e lawe ana iā deucravacitinib i ka hoʻomaikaʻi nui ʻana i kā lākou psoriasis i hoʻohālikelike ʻia me ka poʻe e lawe ana iā apremilast.

Eia naʻe, ʻo ka pono he hoʻokahi mea e noʻonoʻo ai. Ua loaʻa ʻo Apremilast no ka lōʻihi a he palekana maikaʻi. Hiki i kekahi poʻe ke ʻae i kekahi lāʻau lapaʻau ma mua o kekahi.

E noʻonoʻo kāu kauka i nā mea he nui i ke koho ʻana ma waena o kēia mau lāʻau lapaʻau, me ke koʻikoʻi o kāu psoriasis, nā kūlana olakino ʻē aʻe, nā pilina lāʻau lapaʻau, a me kāu mau makemake pilikino e pili ana i nā hopena ʻaoʻao a me ke alapine ʻana o ka dosage.

Nā Nīnau i Nīnau Pinepine ʻia e pili ana iā Deucravacitinib

He Palekana ʻo Deucravacitinib no ka poʻe me ka maʻi puʻuwai?

Me he mea lā he palekana maikaʻi ʻo Deucravacitinib i ka cardiovascular i hoʻohālikelike ʻia me kekahi mau lāʻau lapaʻau psoriasis ʻē aʻe. Eia naʻe, inā he maʻi puʻuwai kou, e loiloi pono kāu kauka i nā pilikia a me nā pōmaikaʻi ma mua o ke kau ʻana i kēia lāʻau lapaʻau.

ʻAʻole i hōʻike nā hoʻokolohua lapaʻau i ka piʻi ʻana o ka pilikia o nā pilikia puʻuwai me deucravacitinib. ʻO ka ʻoiaʻiʻo, hōʻike kekahi mau haʻawina e loaʻa paha iā ia kahi hopena kūʻokoʻa a i ʻole ka hopena maikaʻi i nā mea pilikia cardiovascular.

E nānā kāu kauka i kou olakino puʻuwai i nā manawa maʻamau inā he mau kūlana cardiovascular kou. Hiki iā lākou ke nānā i kou koko a me nā pae cholesterol i kēlā me kēia manawa i ka wā e lawe ana ʻoe i kēia lāʻau lapaʻau.

He aha kaʻu e hana ai inā hoʻohana hewa au i ka nui o Deucravacitinib?

Inā ua lawe ʻoe i ka nui o kāu lāʻau deucravacitinib i kuhikuhi ʻia, e kelepona koke i kāu kauka a i ʻole ke kikowaena mana ʻawa. ʻOiai ua palena ka ʻike e pili ana i ka overdose no ka mea he lāʻau hou kēia, he mea nui e ʻimi koke i ka ʻōlelo aʻoaʻo lapaʻau.

Mai hoʻāʻo e

Inā e hoʻoholo ʻoe a me kāu kauka e hooki i ka deucravacitinib, e kūkākūkā paha lākou i ka hoʻololi ʻana i kahi lapaʻau ʻē aʻe e mālama i ka maikaʻi o kou ʻili. E hilinaʻi ka hoʻolālā hoʻololi i kou kūlana kikoʻī a me nā pahuhopu lapaʻau.

Hiki iaʻu ke inu i ka waiʻona i ka wā e lawe ana i ka Deucravacitinib?

Manaʻo ʻia ka inu ʻana i ka waiʻona maʻalahi he palekana i ka wā e lawe ana i ka deucravacitinib, akā ʻoi aku ka maikaʻi e kūkākūkā i kāu hoʻohana ʻana i ka waiʻona me kāu kauka. Hiki i ka waiʻona nui ke hoʻonui i nā hōʻailona psoriasis a hiki ke hoʻopilikia i nā hopena o kāu lapaʻau.

Hiki i ka waiʻona ke hoʻopilikia i kāu ʻōnaehana pale a me ka hana ate, he mau mea nui e noʻonoʻo ai i ka wā e lawe ana i kekahi lāʻau e pili ana i kāu pane pale.

Inā koho ʻoe e inu i ka waiʻona, e hana me ka maʻalahi a e nānā i ke ʻano o ka hopena i kāu mau hōʻailona psoriasis. ʻIke kekahi poʻe i ka waiʻona e hoʻoulu ai i nā flare-ups, ʻoiai ʻaʻole ʻike nā mea ʻē aʻe i kekahi loli.